We’re a team of clinicians and staff who have dedicated our lives to research, education, and treating those with mental health conditions. We’re especially passionate about helping those with Treatment-Resistant Depression and providing the most advanced therapies available, including Transcranial Magnetic Stimulation (TMS) and esketamine nasal spray, both FDA-approved for advanced depression. Mental health conditions can be profoundly painful and isolating, making it difficult to seek help. Our team provides a unique, patient-centered experience to help you find the appropriate treatment and relief from your symptoms. We’re grateful to be practicing psychiatry during this era in which there are so many new treatment possibilities and new hope for those with mental health conditions.
Our San Diego clinics provide a specialized, rapid-acting approach for residents seeking relief from treatment-resistant depression (TRD). Unlike traditional clinical settings, we offer Spravato® (esketamine) nasal spray in a medically supervised, comfortable environment. As an FDA-approved treatment, Spravato is specifically designed for adults who have not found relief through standard oral antidepressants. This allows patients from the coastal enclaves of La Jolla to the communities of Mission Valley, Chula Vista, and El Cajon to access life-changing care without invasive procedures.
Clinical teams in San Diego focus on achieving rapid symptom relief by targeting the brain's glutamate system and NMDA receptors. While traditional antidepressants can take weeks to work, Spravato often begins to alleviate depressive symptoms within hours or days. Our facilities are strategically located near major San Diego thoroughfares including La Jolla Village Drive and central locations accessible via Interstate 5 and Interstate 8. During your initial consultation, we provide a detailed overview of the esketamine technology to ensure you understand how it targets specific brain pathways associated with mood regulation.
Every San Diego location in the TMS Therapy Near Me directory adheres to rigorous REMS (Risk Evaluation and Mitigation Strategy) safety guidelines. Every treatment course is overseen by licensed psychiatric professionals who monitor patients for at least two hours post-administration to manage potential side effects like dissociation or temporary blood pressure changes.
Clinical teams in San Diego serve the community from convenient locations in La Jolla, Mission Valley, and Chula Vista. Providing local access to this breakthrough technology helps patients avoid the stress of freeway commutes across this sprawling coastal city. Because Spravato sessions require an in-office stay, our appointment schedules are designed to accommodate busy San Diego lifestyles, with extended hours available at select locations.
Yes, Spravato is FDA-approved and has a well-established safety profile. In our California clinics, patients are strictly monitored by healthcare professionals for at least two hours to manage transient side effects such as sedation or dissociation.
Yes, our certified San Diego clinics serve as specialized hubs for residents across the county, offering access to cutting-edge psychiatric technology in convenient locations including La Jolla, Mission Valley, and Chula Vista.
The cost varies based on your individualized plan. Most major California insurance providers, including Kaiser Permanente, Blue Shield of California, and Anthem, cover Spravato for depression. Our staff will help you verify coverage and explore patient assistance programs that can reduce out-of-pocket costs to as little as $10 per treatment.
Clinical teams typically follows a structured schedule: twice-weekly sessions for the first 4 weeks (Induction), followed by once-weekly sessions for the next 4 weeks (Optimization).
Our San Diego facilities primarily treat adults with Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD) with acute suicidal ideation or behavior.
Yes, a referral is generally required to confirm a diagnosis of Treatment-Resistant Depression (TRD), meaning you have not responded to at least two different oral antidepressants.
"*" indicates required fields
